4//SEC Filing
ABIOMED INC 4
Accession 0001179110-13-012808
CIK 0000815094operating
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 5:11 PM ET
Size
16.3 KB
Accession
0001179110-13-012808
Insider Transaction Report
Form 4
ABIOMED INCABMD
AUSTEN W GERALD
Director
Transactions
- Exercise/Conversion
Common Stock $.01 par value
2013-08-05$10.06/sh+8,000$80,480→ 78,200 total(indirect: Footnote) - Sale
Common Stock, $0.01 par value
2013-08-05$22.85/sh−8,000$182,834→ 70,200 total(indirect: Footnote) - Exercise/Conversion
Stock Option (right to buy)
2013-08-05−8,000→ 0 totalExercise: $10.06From: 2006-08-09Exp: 2015-08-10→ Common Stock (8,000 underlying)
Holdings
- 8,000
Stock Option (right to buy)
Exercise: $13.21From: 2007-08-08Exp: 2016-08-09→ Common Stock (8,000 underlying) - 8,000
Stock option (right to buy)
Exercise: $12.69From: 2008-08-13Exp: 2017-08-08→ Common Stock (8,000 underlying) - 12,000
Stock Option (right to buy)
Exercise: $18.63From: 2009-08-12Exp: 2018-08-13→ Common Stock (12,000 underlying)
Footnotes (5)
- [F1]This option becomes exercisable in full on the date set forth in Table II, Column 6.
- [F2]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- [F3]Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- [F4]Represents shares held by the W. Gerald Austen Rev Trust, of which the Reporting Person and his spouse are the Trustees and the Reporting Person's spouse and children are the beneficiaries. The Reporting Person disclaims beneficial ownership of all such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of such shares for purposes of Section 16 or for any other purpose.
- [F5]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $22.6000 and $23.0100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Documents
Issuer
ABIOMED INC
CIK 0000815094
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000815094
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 5:11 PM ET
- Size
- 16.3 KB